Clinical Trial Update: Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing alfuzosin to placebo for chronic prostatitis/chronic pelvic pain syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain Syndrome
• Prostatitis

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Prostatitis | Phase 3 | Status: COMPLETED | Results posted: 2020-06-12